Tratamiento de episodios maníacos y mixtos.
DOI:
https://doi.org/10.25118/2763-9037.2011.v1.1429Palabras clave:
manía, trastorno bipolar, litio, anticonvulsivos, terapia electroconvulsivaResumen
.
Descargas
Métricas
Citas
1. Altamura AC, Lietti L, Dobrea C, Benatti B, Arici C, Dell’Osso B. Mood stabilizers for patients with bipolar disorder: the state of the art. Expert Rev Neurother. 2011 Jan;11(1):85-99. DOI: https://doi.org/10.1586/ern.10.181
2. Amrollahi Z, Rezaei F, Salehi B, Modabbernia AH, Ma-roufi A, Esfandiari GR, Naderi M, Ghebleh F, Ahmadi--Abhari SA, Sadeghi M, Tabrizi M, Akhondzadeh S. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen ad-junctive to lithium in acute bipolar mania. J Affect Di-sord. 2011 Mar;129(1-3):327-31. DOI: https://doi.org/10.1016/j.jad.2010.08.015
3. Baldaçara L, Sanches M, Cordeiro DC, Jackoswski AP. Rapid tranquilization for agitated patients in emer-gency psychiatric rooms: a randomized trial of olanza-pine, ziprasidone, haloperidol plus promethazine, ha-loperidol plus midazolam and haloperidol alone. Rev Bras Psiquiatr. 2011 Mar;33(1):30-9. DOI: https://doi.org/10.1590/S1516-44462011000100008
4. Bertschy G, Gervasoni N, Favre S, Liberek C, Ragama--Pardos E, Aubry JM,
5. Gex-Fabry M, Dayer A. Frequency of dysphoria and mixed states. Psychopathology. 2008;41(3):187-93. DOI: https://doi.org/10.1159/000120987
6. Cipriani A, Rendell JM, Geddes JR. Haloperidol alone or in combination for acute mania. Cochrane Database Syst Rev 2006; 3: CD004362. DOI: https://doi.org/10.1002/14651858.CD004362.pub2
7. Demetrio FN, Soares OT. Interações Medicamentosas em Psiquiatria. Condutas em psiquiatria: consulta rápi-da .1.ed. Porto Alegre: Artmed, 2008; pp. 211-276.
8. Fountoulakis KN, Vieta E. Treatment of bipolar di-sorder: a systematic review of available data and cli-nical perspectives. Int J Neuropsychopharmacol. 2008 Nov;11(7):999-1029. DOI: https://doi.org/10.1017/S1461145708009231
9. Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklo-witz DJ, Marangell LB, Calabrese JR, Nierenberg AA, Sa-chs GS. Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry. 2009 Feb;166(2):173-81. DOI: https://doi.org/10.1176/appi.ajp.2008.08050746
10. Kapczinski F, Dias VV, Kauer-Sant’Anna M, Brietzke E, Vázquez GH, Vieta E, Berk M. The potential use of bio-markers as an adjunctive tool for staging bipolar disor-der. Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1366 -71. DOI: https://doi.org/10.1016/j.pnpbp.2009.07.027
11. Lafer B, Nery FG, Brietzke E. Estabilizadores do humor. In: Clínica Psiquiátrica. Eds. Miguel EC, Gentil V, Gattaz W. Ed. Manole, São Paulo, 2011.
12. Macedo-Soares MB, Moreno DH. Comorbidades. In: Da Psicose Maníaco-Depressiva ao Espectro Bipolar. Orgs. Moreno, RA e Moreno DH. 3.ed., São Paulo, Seg-mento Farma, 2008.
13. Macedo-Soares MB, Moreno RA, Rigonatti SP, Lafer B. Efficacy of electroconvulsive therapy in treatment--resistant bipolar disorder: a case series. J ECT 2005; 21: 31-34. DOI: https://doi.org/10.1097/01.yct.0000148621.88104.f1
14. Malhi GS, Adams D, Lampe L, Paton M, O’Connor N, Newton LA, Walter G, Taylor A, Porter R, Mulder RT, Berk M; Northern Sydney Central Coast Mental He-alth Drug & Alcohol; NSW Health Clinical Redesign Program; CADE Clinic, University of Sydney. Clinical practice recommendations for bipolar disorder. Acta Psychiatr Scand Suppl. 2009;(439):27-46. DOI: https://doi.org/10.1111/j.1600-0447.2009.01383.x
15. Marchetti RL. Terapêutica dos transtornos mentais as-sociados à epilepsia. Condutas em psiquiatria: consulta rápida .1.ed. Porto Alegre: Artmed, 2008; pp. 275-300.
16. Melzer-Ribeiro DL, Teng CT. Emergências psiquiátricas no hospital geral. In: Clínica Psiquiátrica. Eds. Miguel EC, Gentil V, Gattaz W. Ed. Manole, São Paulo, 2011.
17. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011 Mar;68(3):241-51. DOI: https://doi.org/10.1001/archgenpsychiatry.2011.12
18. Moreno DH, Dias RS. Epidemiologia. In: Da Psicose Maníaco-Depressiva ao Espectro Bipolar. Orgs. Mo-reno, RA e Moreno DH. 3.ed., São Paulo, Segmento Farma, 2008.
19. Moreno DH, Moreno RA. Lítio. In: Cordás TA, More-no RA (eds.). Condutas em psiquiatria: consulta rápida .1.ed. Porto Alegre: Artmed, 2008; pp. 145-162.
20. Moreno RA, Moreno DH, Soares MBM, Ratzke R. An-ticonvulsivantes e antipsicóticos no tratamento do transtorno bipolar. Rev Bras Psiquiatr 2004; 26 (suppl. 3): 37-43. DOI: https://doi.org/10.1590/S1516-44462004000700009
21. Mukherjee S, Sackeim HA, Schnur DB. Electroconvul-sive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry 1994; 15: 169-176. DOI: https://doi.org/10.1176/ajp.151.2.169
22. Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cas-sidy F, Beaulieu S,
23. Yatham LN, Berk M; International Society for Bipolar Disorders. The International Society for Bipolar Disor-ders (ISBD) consensus guidelines for the safety moni-toring of bipolar disorder treatments. Bipolar Disord. 2009 Sep;11(6):559-95. DOI: https://doi.org/10.1111/j.1399-5618.2009.00737.x
24. Reinares M, Colom F, Rosa AR, Bonnín CM, Franco C, Solé B, Kapczinski F, Vieta E. The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord. 2010 Jun;123(1-3):81-6. DOI: https://doi.org/10.1016/j.jad.2009.09.009
25. Rigonatti SP, Caires MAF. Eletroconvulsoterapia. In: Cordás TA, Moreno RA (eds.). Condutas em psiquia-tria: consulta rápida .1.ed. Porto Alegre: Artmed, 2008; pp. 197-209.
26. Schwartz TL, Stahl SM. Treatment strategies for dosing the second generation antipsychotics. CNS Neurosci Ther. 2011 Apr ;17(2):110 -7. DOI: https://doi.org/10.1111/j.1755-5949.2011.00234.x
27. Schwartzmann AM, Lafer B. Diagnóstico e tratamento dos estados mistos. Rev Bras Psiq 26 2004; (supl. III): 7-11 . DOI: https://doi.org/10.1590/S1516-44462004000700003
28. Sekhar S, Kalra B, Mendhekar DN, Tekur U. Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study. J Clin Pharmacol. 2010 Jun;50(6):688-92. DOI: https://doi.org/10.1177/0091270009347870
29. Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D. Acute bipolar mania: a systematic review and meta--analysis of co-therapy vs. monotherapy. Acta Psychia-tr Scand. 2007 Jan;115(1):12-20. DOI: https://doi.org/10.1111/j.1600-0447.2006.00912.x
30. Suppes T, Eudicone J, McQuade R, Pikalov A 3rd, Carl-son B. Efficacy and safety of aripiprazole in subpopula-tions with acute manic or mixed episodes of bipolar I disorder. J Affect Disord. 2008 Apr;107(1-3):145-54. DOI: https://doi.org/10.1016/j.jad.2007.08.015
31. Swann AC, Steinberg JL, Lijffijt M, Moeller GF. Conti-nuum of depressive and manic mixed states in patients with bipolar disorder: quantitative measurement and clinical features. World Psychiatry. 2009 Oct;8(3):166-72. DOI: https://doi.org/10.1002/j.2051-5545.2009.tb00245.x
32. Szegedi A, Zhao J, van Willigenburg A, Nations KR, Mackle M, Panagides J. Effects of asenapine on depres-sive symptoms in patients with bipolar I disorder ex-periencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trials. BMC Psychiatry 2011 Jun 20;11:101. DOI: https://doi.org/10.1186/1471-244X-11-101
33. Tamayo JM, Zarate CA Jr, Vieta E, Vázquez G, Tohen M. Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I di-sorder phases: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2010 Jul;13(6):813-32. DOI: https://doi.org/10.1017/S1461145709991246
34. Valentí M, Benabarre A, García-Amador M, Molina O, Bernardo M, Vieta E. Electroconvulsive therapy in the treatment of mixed states in bipolar disorder. Eur Psychiatry. 2008 Jan;23(1):53-6. DOI: https://doi.org/10.1016/j.eurpsy.2007.10.011
35. Wagner KD, Kowatch RA, Emslie GJ et al. A double-blind, randomized, placebo-controlled trial of ox-carbazepine in the treatment of bipolar disorder in children and adolescents. Am J Psychiatry 2006; 163: 1179 –118 6 . DOI: https://doi.org/10.1176/appi.ajp.163.7.1179
36. Yildiz A, Vieta E, Leucht S, Baldessarini RJ. Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials. Neuropsychopharmacology. 2011 Jan;36(2):375-89. DOI: https://doi.org/10.1038/npp.2010.192
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2011 Doris Hupfeld Moreno, Ricardo Alberto Moreno
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Debates em Psiquiatria permite que el (los) autor (es) mantenga(n) sus derechos de autor sin restricciones. Permite al (los) autor (es) conservar sus derechos de publicación sin restricciones. Los autores deben garantizar que el artículo es un trabajo original sin fabricación, fraude o plagio; no infringe ningún derecho de autor o derecho de propiedad de terceros. Los autores también deben garantizar que cada uno atendió a los requisitos de autoría conforme a la recomendación del ICMJE y entienden que, si el artículo o parte de él es fallido o fraudulento, cada autor comparte la responsabilidad.
Reconocimiento-NoComercial 4.0 internacional (CC BY-NC 4.0) - Debates em Psiquiatria es regida por la licencia CC-BY-NC
Usted es libre de:
- Compartir — copiar y redistribuir el material en cualquier medio o formato
- Adaptar — remezclar, transformar y crear a partir del material
El licenciador no puede revocar estas libertades mientras cumpla con los términos de la licencia. Bajo las condiciones siguientes:
- Reconocimiento — Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios<. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.
- NoComercial — No puede utilizar el material para una finalidad comercial.
No hay restricciones adicionales — No puede aplicar términos legales o medidas tecnológicas que legalmente restrinjan realizar aquello que la licencia permite.
